AUVEN THERAPEUTICS: all contributions
2023–2024 · Reported individual contributions grouped by employer.
These are contributions by individuals, not by their employer, industry, or location. Refunds remain negative; memo-only rows are marked and are not additional money.
← Back to AUVEN THERAPEUTICS| # | Reported contributor / location | Reported employer / occupation | Recipient / reporting committee | Date ↕ | Amount ↑ | Election | Filing details / source |
|---|---|---|---|---|---|---|---|
| 181 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | NO VOTE LEFT BEHIND PACC00772848 | 2024-06-30 | $25 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1799957FEC filing ↗ |
| 182 | CORR, PETERST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | ACTBLUEC00401224 | 2023-05-22 | $25 | Primary (P) | EARMARKED FOR VIRGIN ISLANDS FOR PLASKETT (C00528182)Filing 1720554FEC filing ↗ |
| 183 | CORR, PETERST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | DCCCC00000935 | 2023-09-30 | $25 | Primary (P) | * EARMARKED CONTRIBUTION THROUGH ACTBLUE PAC ON 09/30/2023Filing 1754894 · amendedFEC filing ↗ |
| 184 | CORR, PETERST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | DCCCC00000935 | 2023-10-11 | $25 | Primary (P) | * EARMARKED CONTRIBUTION THROUGH ACTBLUE PAC ON 10/11/2023Filing 1754920 · amendedFEC filing ↗ |
| 185 | CORR, PETERST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | ACTBLUEC00401224 | 2023-10-22 | $25 | Not reported | EARMARKED FOR ELECT DIVERSE DEMOCRATS PAC (C00782599)Filing 1752852FEC filing ↗ |
| 186 | COR, PETERST THOMASVI00802 | DRUG DISCOVERY & DEVELOPMENTAUVEN THERAPEUTICS | HMPC00495028 | 2024-02-12 | $27 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1790285 · amendedFEC filing ↗ |
| 187 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPMENTAUVEN THERAPEUTICS | HMPC00495028 | 2024-04-11 | $27 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1790298 · amendedFEC filing ↗ |
| 188 | COR, PETERST THOMASVI00802 | DRUG DISCOVERY & DEVELOPMENTAUVEN THERAPEUTICS | HMPC00495028 | 2024-03-24 | $27 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1790297 · amendedFEC filing ↗ |
| 189 | CORR, PETERST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | STOP REPUBLICANSC00633404 | 2023-07-02 | $30 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1745206FEC filing ↗ |
| 190 | CORR, PETER BST THOMASVI00802 | DRUG DEVELOPMENTAUVEN THERAPEUTICS | DSCCC00042366 | 2024-10-14 | $30 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1840903FEC filing ↗ |
| 191 | CORR, DR PETER BST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | DSCCC00042366 | 2024-11-25 | $30 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1857612FEC filing ↗ |
| 192 | CORR, PETER BST THOMASVI00802 | DRUG DEVELOPMENTAUVEN THERAPEUTICS | DSCCC00042366 | 2024-07-11 | $30 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1826278 · amendedFEC filing ↗ |
| 193 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-05-27 | $30 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875021 · amendedFEC filing ↗ |
| 194 | CORR, PETER BST THOMASVI00802 | DRUG DEVELOPMENTAUVEN THERAPEUTICS | DSCCC00042366 | 2024-07-14 | $30 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1826278 · amendedFEC filing ↗ |
| 195 | CORR, PETER BST THOMASVI00802 | DRUG DEVELOPMENTAUVEN THERAPEUTICS | DSCCC00042366 | 2024-08-14 | $30 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1817683FEC filing ↗ |
| 196 | CORR, PETER BST THOMASVI00802 | DRUG DEVELOPMENTAUVEN THERAPEUTICS | DSCCC00042366 | 2024-05-14 | $30 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1791497FEC filing ↗ |
| 197 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-07-11 | $30 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875029 · amendedFEC filing ↗ |
| 198 | CORR, PETER BST THOMASVI00802 | DRUG DEVELOPMENTAUVEN THERAPEUTICS | DSCCC00042366 | 2024-09-14 | $30 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1833435FEC filing ↗ |
| 199 | CORR, PETER BST THOMASVI00802 | DRUG DEVELOPMENTAUVEN THERAPEUTICS | DSCCC00042366 | 2024-05-13 | $30 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1791497FEC filing ↗ |
| 200 | CORR, PETER BST THOMASVI00802 | DRUG DEVELOPMENTAUVEN THERAPEUTICS | DSCCC00042366 | 2024-09-21 | $30 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1833435FEC filing ↗ |
This small employer group is read directly through the employer index, then sorted and paginated. Only the latest version within matching employer records is shown; amendments that change the employer may affect this grouping. Raw reported names and filing values are preserved. This list covers locally ingested FEC individual-contribution records, not undisclosed or unitemized contributor identities.